Unichem Laboratories Q2 net up 3% at Rs 36.2 crore

PTI New Delhi | Updated on March 12, 2018 Published on October 19, 2013

Drug firm Unichem Laboratories today reported a 3.22 per cent increase in net profit to Rs 36.2 crore for the quarter ended September 30 as sales rose.

The company had posted a profit of Rs 35.07 crore in the corresponding quarter of the previous fiscal, Unichem said in a filing to the BSE.

Total income climbed to Rs 269.57 crore from Rs 264.24 crore a year earlier, it added.

Formulations constitute the core business of the company, which also manufactures active pharmaceutical ingredients (APIs or bulk actives).

Unichem Laboratories is present in therapeutic areas such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterials, anti-infectives and pain management, among others.

Published on October 19, 2013
This article is closed for comments.
Please Email the Editor